These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19487588)

  • 1. G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans.
    Cohn HI; Xi Y; Pesant S; Harris DM; Hyslop T; Falkner B; Eckhart AD
    Hypertension; 2009 Jul; 54(1):71-6. PubMed ID: 19487588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition.
    Maning J; McCrink KA; Pollard CM; Desimine VL; Ghandour J; Perez A; Cora N; Ferraino KE; Parker BM; Brill AR; Aukszi B; Lymperopoulos A
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-protein receptor kinases 2, 5 and 6 redundantly modulate Smoothened-GATA transcriptional crosstalk in fetal mouse hearts.
    Franco A; Zhang L; Matkovich SJ; Kovacs A; Dorn GW
    J Mol Cell Cardiol; 2018 Aug; 121():60-68. PubMed ID: 29969579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension: Are we beta-ARKing up the right tree?
    Attramadal H
    Hypertension; 2009 Jul; 54(1):27-8. PubMed ID: 19487585
    [No Abstract]   [Full Text] [Related]  

  • 5. β2- and β1-Adrenoceptor Expression Exhibits a Common Regulatory Pattern With GRK2 and GRK5 in Human and Animal Models of Cardiovascular Diseases.
    Montó F; Oliver E; Vicente D; Buendía F; Rueda J; Agüero J; Almenar L; Valldecabres C; Rovira E; Muedra V; Noguera MA; Ivorra MD; DʼOcon P
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):478-86. PubMed ID: 26248277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients.
    Lobmeyer MT; Wang L; Zineh I; Turner ST; Gums JG; Chapman AB; Cooper-DeHoff RM; Beitelshees AL; Bailey KR; Boerwinkle E; Pepine CJ; Johnson JA
    Pharmacogenet Genomics; 2011 Jan; 21(1):42-9. PubMed ID: 21127457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G Protein-Coupled Receptor Kinase 2 (GRK2) and 5 (GRK5) Exhibit Selective Phosphorylation of the Neurotensin Receptor in Vitro.
    Inagaki S; Ghirlando R; Vishnivetskiy SA; Homan KT; White JF; Tesmer JJ; Gurevich VV; Grisshammer R
    Biochemistry; 2015 Jul; 54(28):4320-9. PubMed ID: 26120872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.
    Liggett SB; Cresci S; Kelly RJ; Syed FM; Matkovich SJ; Hahn HS; Diwan A; Martini JS; Sparks L; Parekh RR; Spertus JA; Koch WJ; Kardia SL; Dorn GW
    Nat Med; 2008 May; 14(5):510-7. PubMed ID: 18425130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart.
    Eckhart AD; Duncan SJ; Penn RB; Benovic JL; Lefkowitz RJ; Koch WJ
    Circ Res; 2000 Jan 7-21; 86(1):43-50. PubMed ID: 10625304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial G protein receptor-coupled kinase expression correlates with functional parameters and clinical severity in advanced heart failure.
    Agüero J; Almenar L; Montó F; Oliver E; Sánchez-Lázaro I; Vicente D; Martínez-Dolz L; D'Ocon P; Rueda J; Salvador A
    J Card Fail; 2012 Jan; 18(1):53-61. PubMed ID: 22196842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced platelet G protein-coupled receptor kinase 2 in major depressive disorder: antidepressant treatment-induced upregulation of GRK2 protein discriminates between responder and non-responder patients.
    García-Sevilla JA; Alvaro-Bartolomé M; Díez-Alarcia R; Ramos-Miguel A; Puigdemont D; Pérez V; Alvarez E; Meana JJ
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):721-30. PubMed ID: 20493668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of β
    Nash CA; Nelson CP; Mistry R; Moeller-Olsen C; Christofidou E; Challiss RAJ; Willets JM
    Cell Signal; 2018 Nov; 51():86-98. PubMed ID: 30075183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading.
    Hata JA; Williams ML; Schroder JN; Lima B; Keys JR; Blaxall BC; Petrofski JA; Jakoi A; Milano CA; Koch WJ
    J Card Fail; 2006 Jun; 12(5):360-8. PubMed ID: 16762799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development.
    Hullmann J; Traynham CJ; Coleman RC; Koch WJ
    Pharmacol Res; 2016 Aug; 110():52-64. PubMed ID: 27180008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein-coupled receptor kinases in normal and failing myocardium.
    Huang ZM; Gold JI; Koch WJ
    Front Biosci (Landmark Ed); 2011 Jun; 16(8):3047-60. PubMed ID: 21622221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of vascular smooth muscle G protein-coupled receptor kinase 2 enhances alpha1D-adrenergic receptor constriction.
    Cohn HI; Harris DM; Pesant S; Pfeiffer M; Zhou RH; Koch WJ; Dorn GW; Eckhart AD
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1695-704. PubMed ID: 18723764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRK2 Up-Regulation Creates a Positive Feedback Loop for Catecholamine Production in Chromaffin Cells.
    Jafferjee M; Reyes Valero T; Marrero C; McCrink KA; Brill A; Lymperopoulos A
    Mol Endocrinol; 2016 Mar; 30(3):372-81. PubMed ID: 26849467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-termini of GRK2 and GRK3 simulate the stimulating effects of RKIP on β-adrenoceptors.
    Maimari T; Krasel C; Bünemann M; Lorenz K
    Biochem Biophys Res Commun; 2019 Dec; 520(2):327-332. PubMed ID: 31604529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizing a structure-based docking approach to develop potent G protein-coupled receptor kinase (GRK) 2 and 5 inhibitors.
    Waldschmidt HV; Bouley R; Kirchhoff PD; Lee P; Tesmer JJG; Larsen SD
    Bioorg Med Chem Lett; 2018 May; 28(9):1507-1515. PubMed ID: 29627263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and activity of g protein-coupled receptor kinases in differentiated thyroid carcinoma.
    Métayé T; Menet E; Guilhot J; Kraimps JL
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3279-86. PubMed ID: 12107237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.